In the article titled “Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction,” published online August 25, 2021, in JAMA Cardiology,1 the numbers for men and women were given incorrectly in the Key Points, Abstract, text, and Figure 1. In addition, values in the Figure 2 graphs were displayed incorrectly. The article has been corrected.
References
- 1.AbouEzzeddine OF, Davies DR, Scott CG, et al. Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction. JAMA Cardiol. Published online August 25, 2021. doi: 10.1001/jamacardio.2021.3070 [DOI] [PMC free article] [PubMed] [Google Scholar]